A recent survey from Intel revealed that health system decision-makers have considered artificial intelligence as a new element of life. Still, many people are anxious as to whether it could provide safe care.
In a breakthrough finding, revealed through the final analysis of a mid-stage trial, Japanese pharmaceutical firm, Eisai Co and Biogen Inc’s drug for Alzheimer’s proved beneficial for patients who received the highest dose.
The digital health world seems to be continuing its rapid growth where around 70 companies' funding results were announced during the second quarter od 2018, totaling to $2 billion.
A report was issued by the World Health Organization (WHO) recently that the number of people receiving hepatitis C cures was increased from 1 million in 2015 to 1.5 million in 2016. Previously, only a small number of countries took part in hepatitis C treatments.
On Monday Romania’s national food and health safety authority reported the outbreak of African swine fever in southern Tulcea and stated that all pigs, over 44,000, would be euthanized.
Recent news regarding pharma companies in Asia
A shocking report revealed that an error in breast cancer screening tests may have affected a vast number of women across England. Due to a computer algorithm failure dating back to 2009, a group of women was not sent for routine breast cancer screening tests before their 71st birthdays. Public Health England (PHE) predicted that around 450,000 women may have been affected due to these screening errors during 2009.
Saving lives through accurate diagnosis followed by swift treatment is the major outcome of new and pioneering medical inventions and technologies. And it is encouraging to see that the healthcare industry is heading towards this goal. With this in mind, we have listed three medical advances which have helped to change the medical scenario throughout the world.
Key findings of the FHI 2018 allude to the lack of access on account of low skilled physician density and a low number of hospital beds. The study also highlighted the fact that semi-urban and rural areas are yet to leverage the advancements of digital healthcare. It also stated that healthcare professionals in the country were open to the deployment of futuristic technology such as AI and virtual reality in healthcare as compared to the general population.
With the aid of scholarship-funded programs and start-up accelerators, many health start-ups have progressed and attained profitability. Now there is good news for small start-ups who seek funding to solve ongoing global medical issues. RebelBio’s start-up acceleration program offers up to £200K twice every year for life sciences start-ups to carry out scientific works.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.